A hybrid receptor molecule composed of the extracellular ligand-binding domain of the human insulin receptor and the transmembrane and cytoplasmic (proteintyrosine kinase) domains of the chicken sarcoma virus UR2 transforming protein p685a9-has been constructed and expressed in Chinese hamster ovary (CHO) cells. The hybrid is processed normally into a and hybrid .8 subunits, is expressed on the cell surface at high levels, and binds insulin with near-wild-type affinity. Furthermore, insulin stimulates the phosphorylation on tyrosine residues of the hybrid 8 subunit in vivo and the phosphorylation of an exogenous substrate [poly(Glu,Tyr)] in vitro. Thus the hybrid is capable of heterologous transmembrane signaling. However, the hybrid mediates neither the insulin-activated uptake of 2-deoxyglucose nor the incorporation of [3H]thymidine into DNA, suggesting that the physiological response(s) mediated by ligand-activated protein-tyrosine kinases may utilize distinct intracellular mechanisms for postreceptor signaling.
The insulin receptor (IR) is a disulfide-linked heterotetramer composed of two a and two B subunits. Insulin binds to cells with high affinity and stimulates the autophosphorylation of the , subunit of the IR predominantly on tyrosine residues (reviewed in ref. 1) . The primary sequence of the human IR (hIR) protein, deduced from the nucleotide sequence of the human placental IR cDNA (2, 3) , indicates a single polypeptide chain precursor (a,3), which is proteolytically processed during biosynthesis to generate a subunit (735 amino acids; Mr = 84,214) and P subunit (620 amino acids; Mr = 69,703). The presumptive membrane-spanning domain bisects the p subunit. Thus the IR is composed of an extracellular domain (composed of the a subunit and about one-third of the p subunit), which binds insulin, and a cytoplasmic domain (about two-thirds of the 8 subunit), which contains the protein-tyrosine kinase (PTK; EC 2.7.1.112) domain of the IR.
A wide variety of studies implicate the IR kinase in mediating insulin-activated functions such as glucose uptake, glycogen synthesis, and DNA synthesis (4) (5) (6) . However, it is not known whether the IR kinase domain itself conveys specificity for the initiation of insulin responses by cells. In the present study we have employed molecular genetic methods to test this requirement by constructing a hybrid receptor composed of the extracellular domain of the hIR protein fused to the transmembrane and cytoplasmic PITK domain of the chicken sarcoma virus UR2 transforming protein p68gag-ros (7) (8) (9) (10) (11) (12) , with which the hIR is -50% identical (2) . We find that the heterologous IR-ros hybrid when expressed in Chinese hamster ovary (CHO) cells exhibits insulin-activated PTK activity in vivo and in vitro. However, it is nonfunctional as an IR: it mediates neither the insulinactivated uptake of 2-deoxyglucose nor the incorporation of [3H]thymidine into DNA.
MATERIALS AND METHODS
Construction of an Expression Plasmid Encoding the hIRros Hybrid Protein. All manipulations of DNA were according to standard procedures (13) . Enzymes were from New England Biolabs or Boehringer Mannheim. Plasmids were propagated in the DH1 strain of Escherichia coli as described (14) .
The hybrid hIR-ros cDNA was assembled in plasmid pECE, a 2.9-kilobase (kb) expression vector (4), as follows. Plasmid peT, which contains the full-length (-4.5-kb) hIR cDNA inserted into the EcoRI/Xba I sites of pECE (4) , was (i) digested to completion with Xba I, (ii) digested partially with Aat II [which leaves a 3' overhang at base pair (bp) 2983 of the hIR cDNA], and (iii) rendered blunt-ended by treatment with the large (Klenow) fragment of E. coli DNA polymerase for 30 min at room temperature, followed by an additional 30 min at room temperature in the presence of all four deoxynucleoside triphosphates (P-L Biochemicals; 100 ,uM). Then the =5.8-kb fragment containing the pECE vector and 2983 bp of the hIR cDNA, with 5' and 3' blunt ends, was purified by electrophoresis in low-gelling-temperature agarose (SeaPlaque, FMC, Rockland, ME); the product is designated peTAp. The transmembrane domain and the entire cytoplasmic domain (including the PTK domain) of the transforming protein p68gag-1r encoded by the chicken v-ros oncogene were provided by a Hae II (bp 800) to Pvu II (bp 3011) fragment of UR2 DNA (11) . After removal of the 3' Hae II overhang (see above), this -2. (2) ], the Ala residue at the hybrid junction, 10 residues encoded by viral gag sequences, 6 extracellular residues, and the transmembrane domain (29 residues) and cytoplasmic domain (367 residues) encoded by ros sequences (11) . The cDNA contains 72 bp of 3' untranslated sequence after the stop codon (bp 2036) at the end of the p68ag-ros sequence (11) .
Expression and Characterization of the Hybrid Receptor in CHO Cells. The expression plasmid pehIR.ros was transfected into CHO cells and transformants expressing high levels of the hIR-ros protein were selected as described (16 20 Ci/ mmol; 1 Ci = 37 GBq) was added, and after 45 min cells were washed twice with ice-cold Dulbecco's phosphate-buffered saline and solubilized with 0.4 ml of 1% NaDodSO4. Trichloroacetic acid was added to the lysate to a final concentration of 10% and the resulting precipitate was pelleted by centrifugation (2000 x g, 20 min, 4°C). After aspiration of the supernatant, the pellet was dissolved in 0.5 ml of 0.4 M NaOH, followed by 0.25 ml of 1 M Tris HCl, pH 7.4, and 0.25 ml of 1 M HCl and the radioactivity of the solution was then measured. Subunits. In CHO cell lines that express the wild-type hIR (CHO.T cells), the hIR mAb specifically immunoprecipitates labeled bands of =200, 135, and 95 kDa, consistent with the molecular masses of the IR precursor and a and 13 subunits, respectively (4, 17) (Fig. 1A, lane 2 from left) . These bands are not present when a control antibody (normal mouse IgG) is employed (Fig. 1A, lane 1) . The A prominent feature of the deduced amino acid sequence of the a subunit of the hIR is the cysteine-rich region: this domain may be involved in the formation ofthe intermolecular disulfide bridges required for the oligomeric structure of the receptor. How does the presence of heterologous p68-ros transmembrane and cytoplasmic domains influence this intermolecular behavior of the hybrid IR-ros molecule? Electrophoretic analysis under nonreducing conditions of total cell lysates of CHO.IR.ros cells covalently cross-linked with 125I-insulin reveals several high molecular weight species (Mr >> 200,000) after immunoprecipitation with either the hIR mAb (Fig. 1B,  lane 5) or ros-specific antibody (Fig. 1B, lane 6) but not control (normal mouse IgG, Fig. 1B, lane 4) antibodies. The mobility of these oligomers is indistinguishable from that observed for cross-linked hIR purified from human term placenta (Fig. 1B,  lane 2) . Thus the IR-ros hybrid also displays the propensity for oligomerization characteristic of the wild-type hIR.
RESULTS AND DISCUSSION
The IR-ros Hybrid Exhibits Ligand-Activated Transmembrane Signaling. Is the hybrid IR-ros molecule capable of transmembrane signaling? CHO.T cells metabolically labeled with 32Pi exhibit a basal level of phosphorylation of the hIR ,l subunit ( Fig. 2A) , which is known to occur predominantly at serine residues (20) . Incubation of such cells with insulin stimulates the incorporation of 32p; into the p3 subunit, both total and on tyrosine (~8-fold and -14-fold, respectively). In (21)], and (ii) insulin-responsive cells contain a non-IR, insulin-dependent serine kinase (20) , it is possible that the insulin-dependent phosphorylation that we observe is a result of phosphorylation in trans by one of these alternative mechanisms. To distinguish between the various possibilities we have examined the kinase activity of IR-ros hybrid in vitro with the use of a specific mAb (17A3) that can distinguish endogenous CHO IR from the IR-ros hybrid (see Table 1 ) and completely blocks IR autophosphorylation on tyrosine residues.
In these experiments, insulin stimulates the phosphorylation of poly(Glu,Tyr) by about 2-fold (Fig. 2B) . Neither the basal nor the insulin-dependent level of substrate phosphorylation is affected by the addition of mAb 17A3. Thus we conclude that the observed phosphorylation of an exogenous substrate in vitro is a consequence of the stimulation by insulin of the IR-ros hybrid molecule. It is therefore likely that the observed tyrosine phosphorylation of the IR-ros hybrid ,B subunit in vivo (see Fig. 2A ) is a consequence of insulin activation of this hybrid kinase. Thus this molecule is apparently capable of this initial aspect of transmembrane signaling-i.e., transduction of the insulin signal across a at 37°C with 32Pi and subsequently incubated with or without 1 ,uM porcine insulin for 5 min at 37°C. Immunoprecipitates with the appropriate antibodies were then prepared from nonionic detergent extracts of such cells and examined by NaDodSO4/PAGE and autoradiography. To directly compare total phosphorylation with phosphorylation on tyrosine residues, a companion gel for each experiment was treated at alkaline pH, which preferentially hydrolyzes serine phosphate versus tyrosine phosphate (19) . The amount of radioactivity incorporated into the IR 1 subunit was quantitated in each case by measuring the radioactivity in the excised band of -95-kDa protein. heterologous transmembrane domain (derived from p68gag-rs) and stimulation of a heterologous PTK domain. It is of interest to note that the IR-ros molecule exhibits a high level of basal autophosphorylation of the hybrid 83 subunit in vitro. This phosphorylation is not stimulated by 1 1uM porcine insulin (data not shown). This contrasts with the in vivo phosphorylation results of Fig. 2A,' in which the IR-ros phosphorylation is very low basally and is stimulated by insulin. p68gag-rs is also phosphorylated basally both in vivo (predominantly on serine but also on tyrosine) and in vitro [exclusively on tyrosine (8)]. Thus the extracellular domain of the hIR is able to regulate the activity of the IR-ros hybrid in vivo (presumably in concert with cellular tyrosine phosphatases), while the PTK domain of the hybrid is autonomously active in vitro.
CHO.IR.ros cells grow to contact inhibition and do not form foci or grow in soft agar. Furthermore, the incubation of such cells with porcine insulin at a range of concentrations (10-6 to 10-12 M) has no influence on their growth in plastic culture dishes or in soft agar (data not shown), even though the IR-ros molecule is phosphorylated on tyrosine residues in vivo in the presence of insulin (see Fig. 2A ; see also below). The inability of IR-ros to transform CHO cells could be due to resistance of this cell line to transformation by the UR2 ros oncogene or to the structural modification of the p685a-r°s protein introduced by construction of the IR-ros hybrid.
The Thus the IR-ros hybrid does not mediate either this long-term aspect of insulin action (thymidine uptake, Fig. 3B ) or the short-term uptake of 2-deoxyglucose (Fig. 3A) . The PTK Family-Specificity for the Physiological Response? All of the evidence to date supports the hypothesis that the IR requires ligand-activated PTK functions to initiate the insulin response by cells (1, (4) (5) (6) . The present study adds further support to this conclusion. By substitution of a homologous PTK for that of the hIR, we find that although such a hybrid is capable of insulin-dependent transmembrane signaling (phosphorylation of the hybrid /3 subunit on tyrosine residues), the hybrid IR-ros molecule does not function as an IR in such cells: it mediates neither short-term (uptake of 2-deoxyglucose) nor long-term (incorporation of [3H]thymidine) effects of insulin. This suggests (i) that the hIR PTK domain conveys a specificity for initiating the insulin response that the p68gag-rs PTK (though -50% identical) cannot and (ii) that a functional hIR extracellular domain alone is not sufficient for generation of the insulin response (e.g., ligand-induced aggregation). While the IR-ros hybrid is nonfunctional as an IR, the fact that it can mediate one aspect of transmembrane signaling (ligand-dependent tyrosine phosphorylation) encourages us to pursue the experimental strategy of transmembrane receptor domain swaps employed in the present study as an approach to the role of individual PIK domains in the generation of the biological specificity of the transmembrane receptors of which they are an integral part.
